HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Australia
2018378200
Filed on 2020-06-12
2018378200
Filed on 2020-06-12
ANTI-CD276 ANTIBODIES (B7H3)
US Patent 11,851,498
Filed on 2020-03-09
Filed on 2020-03-09
PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO
Japan
2020-068338
Filed on 2020-04-06
2020-068338
Filed on 2020-04-06
USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS
US Patent 11,702,472
Filed on 2020-03-17
Filed on 2020-03-17
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
US Application 16/760,138
Filed on 2020-04-29
Filed on 2020-04-29
CANCER TREATMENT USING EXISTING MICROBIAL IMMUNITY
South Korea
10-2020-7016052
Filed on 2020-06-04
10-2020-7016052
Filed on 2020-06-04
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
Japan
2020-524774
Filed on 2020-05-07
2020-524774
Filed on 2020-05-07
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
European Patent
18819232.2
Filed on 2020-05-07
18819232.2
Filed on 2020-05-07
NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
China
201880071646.5
Filed on 2018-11-06
201880071646.5
Filed on 2018-11-06